CANCER2024

8th World Cancer Congress - 2024

th th
9 - 10 March, 2024 New Delhi, India
Theme: Exploring New Horizons in Oncology
and Cancer Research

Organised By Suported By
About The Conference

Dear Speakers/Delegates/Attendee,

Arjyopa Healthcare welcomes you to attend the 8th World Cancer Congress - 2024 during March
9th - 10th, 2024 at New Delhi, India. We cordially invite all the participants interested in sharing
their knowledge and research in the arena of Oncology and Cancer Research. From feedback
received, the previous Congresses 2016, 2017, 2018, 2019, 2020, 2021, 2022 resulted in fruitful
collaborations and rewarding experiences for the delegates who left the events with concrete tools
and solutions that helped them enhance their work practice and impact. As hosts, we already feel
very excited to create the same energetic and inspiring atmosphere during the Congress week,
adding local flavors and new perspectives such as the role of complementary treatment in cancer
to the programme.

The 8th World Cancer Congress - 2024 will also explore the new ideas and concepts on global
scale and the topics Cancer Biology & Genetics, Organ-Defined Cancers, Oncology: Sub-
Specialities, Radiation Oncology, Surgical Oncology, Cancer & Stem Cell Therapy, Precision
Cancer Medicine & Oncology, Cancer Biomarkers, Cancer Epidemiology, Cancer Prevention &
Research, Cancer Therapy & Treatments, Cancer Pharmacology, Cancer Vaccines, Cancer
Immunology & Immunotherapy, Oncology Nursing and Care, Complementary & Alternative
Methods and Cancer, Cancer Awareness and Survival, Cancer: Lifestyle and Nutrition, Cancer:
Psychological & Social Aspects. The 8th World Cancer Congress – 2024 will also focus on Cancer
Stem Cells, Cancer Basic & Applied Research Tumor, Anti Cancer Drug Discovery, Clinical
Oncology and Personalized Cancer Medicine. It will give us novel insight into the complexity of the
connections between Cancer and Metabolism &Immune Checkpoints, Cancer Biomarkers,
Cancer Epidemiology, Cancer Prevention & Research, Cancer Therapy & Treatments, Cancer
Pharmacology, Cancer Vaccines, Cancer Immunology & Immunotherapy, Oncology Nursing and
Care, Complementary & Alternative Methods and Cancer, Cancer Awareness and Survival,
Cancer: Lifestyle and Nutrition, Cancer: Psychological & Social Aspects, to deliver an outstanding
program with the right balance of clinical relevance, which covers the entire spectrum of practice
issues in Cancer Research and Treatments.

Thus, the urgent need to mobilize our efforts, promote cancer advocacy more efficiently and
develop effective national policies and plans for prevention, early detection, care and support.

We look forward to the honour of welcoming you at New Delhi during conference.
Chairman Message

Dear Delegates/Speakers/Attendee.

On behalf of the Organizing Committee, it is my pleasure to invite all of the great scientists,
academicians, young researchers, Business delegates and students from all over the world to
attend the 8th World Cancer Congress – 2024 which has been scheduled from March 9th – 10th,
2024. The 8th World Cancer Congress – 2024 will be hosted at New Delhi, India and will be
organized with the theme of “Exploring New Horizons in Oncology and Cancer Research”.

The 8th World Cancer Congress - 2024 will also explore the new ideas and concepts on global
scale and the topics Cancer Biology & Genetics, Organ-Defined Cancers, Oncology: Sub-
Specialities, Radiation Oncology, Surgical Oncology, Cancer & Stem Cell Therapy, Precision
Cancer Medicine & Oncology, Cancer Biomarkers, Cancer Epidemiology, Cancer Prevention &
Research, Cancer Therapy & Treatments, Cancer Pharmacology, Cancer Vaccines, Cancer
Immunology & Immunotherapy, Oncology Nursing and Care, Complementary & Alternative
Methods and Cancer, Cancer Awareness and Survival, Cancer: Lifestyle and Nutrition, Cancer:
Psychological & Social Aspects

WCC2024 will be the best platform for all the oncologists, hematologists, research scholars,
students who are working in this field to exchange their knowledge related to Oncology Research.
This international event is an effort to understand the underlying biological procedures which are
amended to increase effectiveness, precision, survivability and quality of life.

We look forward to the honour of welcoming you at the summit.

With Warm Regards

Padma Shri Dr. Kodaganur . S. Gopinath
Consultant Surgical Oncologist & Director
HCG, India
Past Conference Report

With a great support from our Collaborators, Sponsors and Organizing Committee, Arjyopa
Healthcare had successfully completed the 7th Edition of World Cancer Congress – 2022 which was
held from 19th – 20th November, 2022 at Ramanashree California Resort, Yelahanka, Bangaluru,
India. The theme is this year conference was “Exploring New Horizons in Oncology and Cancer
Research”.

The Conference was organized under the leadership (Chairman) of Padma Shri Dr. K. S. Gopinath,
Senior Oncologist and Director, HCG.

The 7th World Cancer Congress – 2022 was a great success where eminent keynote speakers from
various reputed companies, Universities, Oncology professionals assembled to hear a
comprehensive overview of practice-changing new data, to discuss current issues, and to take part in
the networking opportunities. A total of 600+ participants attended this event, which included 120+
Speakers and Faculty. The 7th World Cancer Congress – 2022 had received around 250+ Abstracts
for presentation out of which 120+ had been Accepted for Presentation at the summit. The event
welcomed delegates from Europe, the Middle East, Asia, Africa, Australia and the Pacific region, as
well as North, Central, and South America.

The meeting was embarked with an opening ceremony followed by Keynote Sessions and followed by
series of lectures (Oral & Posters) delivered by Honorable Guests and members of the Keynote forum.

The 7th World Cancer Congress – 2022 was inaugurated by:

ª Dr. Tapas Kundu, Ex-Director, CDRI

ª Padma Shri Dr. K S Gopinath, Director, HCG
ª Dr. Paul Sebastian, Senior Surgical Oncologist and Head, TATA Trust

th
The 7 World Cancer Congress – 2022 had also hosted 20+ Keynote Speakers and some of the top
notch speakers are:

ª Padma Bhushan Dr. Suresh H. Advani, Senior Oncologist, Jaslok Hospital, INDIA
ª Padma Shri Dr. Rajendra A Badwe, Director, Tata Memorial Centre, INDIA
ª Padma Shri Dr. Kamini Rao, Founder and Director, MILANN, INDIA
ª Dr. G K Rath, Chief-Radiation Oncologist, AIIMS, INDIA
ª Dr. Sudeep Gupta, Director, ACTREC, INDIA
ª Dr. Birandra K Sinha, Senior Scientist, NIH, USA
ª Dr. Bhagavatula Moorthy, Professor, Baylor College of Medicine, USA
ª Prof. Madhavan Nair, Distinguished Professor, Florida International University, USA
ª Prof. Kailash Narayan, Professor, Peter MacCallum Cancer Centre, AUSTRALIA
ª Prof. Gokul M. Das, Professor, Roswell Park, USA
ª Prof. Ajit K Saxena, Prof & HOD, Dept. of Pathology, AIIMS, INDIA
ª Dr. Shashank Pandya, Director, Gujarat Cancer & Research Institute, INDIA
ª Dr. Ragavendra Rao, Director, CCRYN-Ministry of Ayush, INDIA
ª Prof. Anuraag Shrivastava, Professor, The University of Winnipeg, CANADA
ª Dr. Praveen Anand, Professor, Imperial College London, UK
ª Dr. Hemant Sarin, Freelancer Investigator, USA
ª Dr. Vikas LB Jadhav, Professor, Dr. DY Patil Medical College, INDIA
th
The 7 World Cancer Congress had also hosted two Panel Discussion i.e. a) Panel Discussion on
Head and Neck Cancer under the Leadership of Dr. Viswanath S. and with the support from Biocon
Biologics Limited b) Panel Discussion on Yoga and Naturopathy in Cancer Treatmant under the
leadership of Dr. Ragavendra Rao and with the support from CCRYN-Ministry of Ayush.
 th
The 7 World Cancer Congress – 2022 has also hosted 25+ Industry Speakers, some of the top
notch speakers are:

ª Dr. Paul Sebastian, Senior Surgical Oncologist and Head, TATA Trust
ª Dr. Tejas Shah, Consultant and Business Head, Krsnaa Diagnostics Ltd.
ª Dr. Deepak Kumar,Radiation Oncology, Ranchi Cancer Hospital and Research Centre, INDIA
ª Dr. Karthik SDS, Surgical Oncologist, SVICCAR, INDIA
ª Dr. P. Nageswara Reddy, Medical Oncologist, SVICCAR, INDIA
ª Dr. Vikram Sahane, Manager, Public Health, Tata Trusts, INDIA
ª Dr. Vinu Sarathy P., Consultant - Medical Oncology, Bangalore Baptist Hospital, INDIA
ª Dr. Kunal Sharma, Associate Director & Section Head, SRL Diagnostics, INDIA
ª Dr. Ghanshyam Biswas, Consultant - Medical Oncology, American Oncology Institute, INDIA
ª Dr. Krishna Prasad, Medical Oncologist, Mangalore Institute of Oncology, INDIA
ª Dr. Prasad Narayanan, Sr. Consultant & Director, Cytecare Cancer Hospital, INDIA
ª Dr. Raghvendra Rao, Director, CCRYN-Ministry of AYUSH, INDIA
ª Dr. Viswanath S, Senior Medical Oncologist, Apollo Hospital, INDIA
ª Dr. Ravi Thipeeswam, Senior Medical Oncologist, HCG Cancer Centre, INDIA
ª Dr. Poornima, Senior Onco Surgeon, ESI Hospital,INDIA
ª Dr. Sridhar PS, Senior Radiation Oncologist, Cytecare Hospital, INDIA
ª Dr. Harish P., Senior Medical Oncologist, Cytecare Hospital, INDIA
ª Dr. Sachin Jadhav, Senior Haemato Oncologist, HCG Group of Hospitals, INDIA
ª Gaurav Parchani, Co-Founder & CTO, Dozee, INDIA
ª Dr. Taisif Thangalvadi, Director and General Manager, NURA, INDIA & JAPAN
ª Dr. Amritanshu Ram, HEAD CAM, HCG, INDIA
ª Dr. Prasann Shankar, Professor, TDU, INDIA
ª Dr. Rudresh BT, Ashwini Homeo Clinic, INDIA

We would like to thank our Keynote Speakers for their support in making this event a great success. It
wouldn't have been possible without the support of our Media Partners who helped us in promoting this
event. We thank our Media partners for their support in helping us reach greater audience. We also
would like to thank all our Speakers and Delegates for sharing their valuable time with us, sharing their
research work with our peer network. We are very glad to have shared a great relationship with all
these attendees, associations and we hope to see even greater support in our upcoming events. We
would also like to thank Chairs and Co-chairs of the conference.
Focus of The Conference

The 8th World Cancer Congress - 2024 is one of the world leading international cancer
conferences. The 8th World Cancer Congress - 2024 organised by Arjyopa Healthcare unites
researchers with diverse expertise in cancer research along with oncologists to discuss most
intensively pursued topics of investigation. The aim and goal of the conference are to bridge
basic and clinical aspects of the genesis, progression, prognosis, prevention, and treatment of
cancer. The summit is focused upon disease management, prevention, strategies for early
diagnosis, specific classes of therapeutic agents, results of a clinical trial, an emerging
interventional technique, supportive care, and rehabilitation/reconstruction. The Summit has
been hosted in New Delhi, which will set a perfect backdrop for the 8th World Cancer Congress-
2024. The conference will provide an ideal platform for knowledge transfer, B2B networking and
collaborations along with a delightful experience of a scientific meeting combined with social
evenings.

Why you Should Attend this Summit

« Learn about new Innovations and various future scope.

« Translate technological capabilities into clinical applications, relevant to daily practice.
« Connect and exchange with technology developers.
« Network with Health main stakeholders in Healthcare Sector.
« Contribute to driving and directing the fast growing field of Health.

Benefits to the Attendee

« Certificates will be provided to all speakers, delegates and students

« Opportunity to meet world’s renowned at this event
« Keynote forums by Prominent Surgeons & Professors
« Best platform for Global business and networking opportunities
« Oral/Poster presentations by Young Researchers
« Best poster award for students

Benefits to the Exhibitor

« Exposure to the international environment would increase the possibility of new companies.
« Opportunity to demonstrate your company's latest technologies, new products, or service
your business to a wide range of international participants.
« Increase business by our Conference participants through lead generation.
« It takes a lot of time, effort and drive to create a successful company, so it's always nice to
have a network of colleagues and associates to draw energy from individuals who share a
common drive and objective.
« Conferences in Surgery provide opportunities for more attention and contemplation that
could help you move your company to the next stage.
« Benchmarking main organization plans and moving it forward.
« Get feedback from trustworthy people at our Conference to your company questions and
challenges.
« Logo and Branding On our Conference banner, website and other proceedings.
Abstract Submission

Authors are invited to submit abstract(s) using the submission form on this page. Abstracts should
contain sufficient detail on the techniques used and the results, which will be shown. You will
receive a confirmation when the abstract has been received. Please contact the conference
secretariat if you did not receive confirmation within 5 working days. Submission implies the intent
of at least one author to register, attend the symposium and present the paper orally or in poster
format. Contributions will only be finally accepted after registration and payment of the
conference fee. The abstract will be reviewed, and you will be notified of acceptance.
ª The entire body of the abstract, excluding tables, must not exceed 250 words. Spaces are
not included in this number. Title, authors’ names, affiliations, figures, and tables are not
included in the character count.
ª The abstract may be structured (i.e., abstracts divided into sections using terms such as
Introduction, Methods, Results, Conclusions, etc.) or unstructured.
ª Do not use bold type or underline formatting. Italic type is acceptable.
ª Text may be in multiple paragraphs.
ª Any references should be noted as citations within the text and not as footnotes at the end
For abstract submission kindly visit https://www.worldcancercongress.in/ or email us at
info@worldcancercongress.in
Important Dates
1st Phase Abstract Submission Deadline: 17th November, 2023
Early Bird Registration Closes: 27th February, 2023

Key Tracks

© Track 1: Bladder Cancer © Track 23: Microbiome & Inflammation

© Track 2: Bone Cancer
© Track 3: Brain Cancer
© Track 4: Breast Cancer
© Track 5: Cancer Genetics & Genomics
© Track 6: Cancer Immunotherapy & Vaccines
© Track 7: Cancer Metabolism
© Track 8: Cell Signalling & Regulation
© Track 9: Cell-Based Therapy
© Track 10: Chemical Biology
© Track 11: Chronic Myeloid Leukemia
© Track 12: Chronic Lymphocytic Leukemia
© Track 13: Developmental Biology
© Track 14: Endocrine Cancer
© Track 15: Epidemiology
© Track 16: Epigenetics
© Track 17: Oncology
© Track 18: Imaging
© Track 19: Immunology
© Track 20: Lung Cancer
© Track 21: Lymphoma
© Track 22: Palliative Care
© Track 24: Molecular Pathology & Diagnostics
© Track 25: Multiple Myeloma
© Track 26: Nanotechnology
© Track 27: Neuroscience & Neuro-Oncology
© Track 28: Renal Cell Carcinoma
© Track 29: Sarcoma
© Track 30: Skin Cancer
© Track 31: Side Effect Management
© Track 32: Solid Tumor Oncogenesis
© Track 33: Stem Cells
© Track 34: Genome Integrity
© Track 35: Gynecologic Cancer
© Track 36: Targeted Therapy
© Track 37: Urologic Cancers
© Track 38: Pancreatic Cancer
© Track 39: Pediatric Cancer
© Track 40: Prostate Cancer
© Track 41: Gastrointestinal Cancer
© Track 42: Head & Neck Cancer
© Track 43: Hematologic Malignancies
© Track 44: HPV & Cervical Cancer
Registration Details

For National Delegates

Early Bird Post Early Bird Normal Spot
Particulars Registration Registration Registration Registration
Till 27th Till 17th Till 17th On 9h
February, 2023 August, 2023 February, 2024 March, 2024
General Category /
Faculty / Medical INR 5999 INR 6999 INR 7999 INR 8999
Practioner
Research Scholar / INR 4999 INR 5999 INR 6999 INR 7999
PhD Scholar
Student(UG & PG) INR 3999 INR 4999 INR 5999 INR 6999

Industrial Participant INR 10999 INR 11999 INR 12999 INR 13999

Accompanying Person INR 4999 INR 4999 INR 4999 INR 4999

For International Delegates

Early Bird Post Early Bird Normal Spot
Particulars Registration Registration Registration Registration
Till 27th Till 17th Till 17th On 9th
February, 2023 August, 2023 February 2024 March, 2024
General Category USD 399 USD 599 USD 699 USD 799

PhD Scholar / Student USD 299 USD 499 USD 599 USD 699

Package A USD 1299 USD 1499 USD 1699 NA

Package B USD 1499 USD 1699 USD 1899 NA

E-Poster USD 199 USD 299 USD 399 NA

You can also Make NEFT/RTGS/IMPS/SWIFT TRANSFER or Prepare Cheque/Draft in the name of
ARJYOPA HEALTHCARE LLP and send it to the below provided address along with the duly filled
registration form

Account Name: Arjyopa Healthcare LLP

Name of the Bank: HDFC BANK
Branch Name: DumDum Cantonment, Kolkata
Nature of Account: Current Account
Account Number: 50200035797200
IFSC Code: HDFC0000106
Swift Code: HDFCINBBCAL
Country: INDIA

Kindly send your Cheque/Draft to the below mentioned address

ARJYOPA HEALTHCARE
2RBC Road, Gora Bazar, Dumdum Cantonment, Kolkata - 700028, WB, India
Ph: +91 7002-412-271 Whatsapp: +91 7002-412-271 E: info@worldcancercongress.in
Tentative Conference Agenda
th
Day 1: 9 March, 2024

08:00 AM - 09:00 AM REGISTRATIONS OPENS

09:00 AM - 09:30 AM INAGURATION OF THE CONFERENCE
09:30 AM - 10:50 AM KEYNOTE ADDRESS(ORGAN DEFINED CANCER)
The Session will explore the different types of organ cancer such as Brest Cancer,
Lung Cancer, Cervical Cancer, Urologic Cancers, Pancreatic cancer, Pediatric
cancer, Prostate Cancer, Bladder cancer, Bone cancer, Brain cancer. The Session
will also cover the latest advancement in the treatment of organ defined cancer, its
prevention and also the future scope.

10:50 AM - 11:00 AM NETWORKING BREAK

11:00 AM - 01:00 PM CANCER BIOMARKERS & NOVEL THERAPEUTICS
Cancer biomarkers are emerging as important tools for disease diagnosis,
prediction and prognosis

The Session will focus on:

ª Cancer genomics and biomarkers for breast cancer, prostate cancer and
more
ª The design of novel compounds and conjugates for high selective targeting
in treatment.
ª Synthetic and medicinal chemistry of anticancer agents.
ª Mathematical and statistical modeling of cancer data.
ª Oncolytic viruses as novel cancer therapeutics.

01:00 PM - 02:00 PM LUNCH & NETWORKING BREAK

02:00 PM - 04:00 PM CLINICALS TRIALS IN ONCOLOGY
Although less than 5% of patients with cancer are enrolled in clinical trials, such
trials represent an important link between basic cancer research and clinical
practice. Clinical trials serve as the foundation for evidence-based medicine by
addressing specific clinical questions that may lead to improvements in current
clinical practice.

This session will basically focus on finding a new ways to:

ª Treat cancer
ª Find and diagnose cancer
ª Prevent cancer
ª Manage symptoms of cancer and side effects from its treatment.
ª Different Phases in clinical Trials.
ª Biological, Clinical, and Psychosocial Correlates at the Interface of
Cancer and Aging Research.

04:00 PM - 04:10 PM NETWORKING BREAK

04:10 AM - 06:30 PM HIGH IMPACT PREVENTION AND RISK FACTOR REDUCTION

The Session will explore primary prevention, including health promotion,
examples of best practice in new evidence-based prevention strategies, and
vaccines. Exposure to environmental risk factors unhealthy environments will be
included, as well as new areas of development in policy, programme
management, communications, and education.
 th
Day 2: 10 March, 2024
08:00 AM - 09:00 AM REGISTRATIONS OPENS
09:00 AM - 11:00 AM CANCER DIAGNOSTICS: FROM CUTTING EDGE TO DAILY REALITY
Earlier and better diagnosis is fundamental to achieving improved outcomes in
cancer, and it is therefore heartening to witness revolutionary technological
improvements in this area, including liquid biopsies, genetic testing and exciting
advances in the field of imaging.But serious challenges remains in not only
bringing these breakthroughs into daily practice, but also separating hype from
reality where required, understanding any necessary caveats to their application,
meeting new unmet needs (e.g. patient counseling on genetic testing) and
considering the challenges to existing service models (e.g. direct to consumer
testing and the role of primary care in utilizing new tools for diagnosis).

The Session will focus on:

ª Cancer screening and early detection and prevention.
ª Molecular diagnostics.
ª Personalized genomics and clinical biomarkers.
ª Digital cancer pathology and imaging
ª Chemotherapy and biological therapeutics.
ª Innovational combinational therapies

11:00 AM - 11:10 AM NETWORKING BREAK

11:10 AM - 01:10 PM TRANSALATION ONCOLOGY
Translational Oncology forms the bridge between basic research and clinical
practice thereby holding the key to the progress in oncology. Tumour
heterogeneity, Liquid biopsies, and Immunotherapy play a vital role in
Translational Oncology.

The Session will focus on:

ª Cellular and genetic oncology
ª Laboratory concepts from bench to bedside
ª Cancer microenvironment
ª Cancer trends and Opportunities
ª Radiation Oncology

01:10 PM - 02:00 PM LUNCH & NETWORKING BREAK

02:00 PM - 04:00 PM ANTI-CANCER DRUG DISCOVERY
Global Anticancer Drug market size is expected to reach USD 145.2 Billion in
2023, at a CAGR of 6.7% from 2017 to 2023. The growth of the anticancer drug
market is attributed to the growing awareness towards cancer diagnosis and
treatment, and increasing incidence of targeted disease(cancer, skin cancer, and
oral cancer among others),coupled with increasing research and development
activities.
The key players dealing in the anticancer drug market are Roche Holding Ltd,
Celgene, Johnson & Johnson, Pfizer, Bristol-Myers Squibb, Novartis,
AstraZeneca, Teva Pharmaceutical, Eli Lilly, Bayer, and GlaxoSmithKline among
others.

This Session will focus on:

ª New Anti-Cancer Drug Development.
ª Targeted Drug Delivery.
ª Anticancer Plant-Derived Drugs.
ª Anti-Cancer Generic Medicine
ª Herbal and Traditional Anti-Cancer Medicine
ª Alternative treatments and therapeutics

04:00 PM - 04:20 PM NETWORKING BREAK

04:20 AM - 06:00 PM CULTURAL EVENTS AND AWARD CEREMONY
2024 WCC Award Show

Renato Dulbecco Memorial Award

Eligibility
­ Senior Scientist or Researcher e.g. Senior Faculty, Dean, Senior Scientist) are the
focus of this event.
­ The topic must fit into scientific sessions of the conference.
­ Each individual participant is allowed to submit only one paper (as first author or co-
author).
­ All authors should have senior position or faculty position.
­ Participants should be above the age of 50 years.
­ Actively distribute information and promote the benefits of education and career
matters.

Edward Keenedy Memorial Award

Eligibility
­ Junior Scientist or Researcher e.g. Associate Professor, Assistant Professor etc.)
are the focus of this event.
­ The topic must fit into scientific sessions of the conference.
­ Each individual participant is allowed to submit only one paper (as first author or co-
author).
­ All authors should have junior position or faculty position.
­ Participants should be below the age of 50 years and above the age of 30.
­ Actively distribute information and promote the benefits of education and career
matters.

Young Investigator Award

Eligibility
­ Young Investigator (e.g. Post-Graduate students, Post-doctoral fellows, Trainees,
Junior faculty) are the focus of this event.
­ The topic must fit into scientific sessions of the conference.
­ Each individual participant is allowed to submit only one paper (as first author or
co-author).
­ Author should not have senior position or faculty position.
­ Participants should be below the age of 30 years.
­ Opportunity for young researchers to learn about the research areas of their peers to
increase their capacity as multi disciplinary researchers.
­ Actively distribute information and promote the benefits of education and career
matters.
Sponsorship Opportunity

Arjyopa Healthcare and 8th World Cancer Congress - 2024 cordially invite your “Business Centre” at the
International Convention for scientific, Medical and Technological advancement in healthcare scheduled
from 9th - 10th March, 2024 at New Delhi, India

The conference will have the industry stalwarts speaks on various topics related to innovation in medicine
and advancement of healthcare, especially in areas of cancer and oncology from India as well as across the
globe. First-of-its-kind summit will proactively invite global enterprise to initiate their ventures in India as well
as invest in India healthcare ventures. The Convention is set to create a fresh wave of interest in healthcare
industry and your esteemed presence will enrich this convention, making it as milestone in the emergent
healthcare sector

Sponsorship Packages

Sponsorship Package Name: Exhibitor Amount: INR 1,39,000

Facilities: (Excluding 18% GST)

1) 2 complimentary registrations
2) One complimentary exhibition spaces of dimension 2X2 sq.metre (Bare Space)
3) Logo recognition on website, brochure, and all other marketing material and stationery.
.
4) 2 insert provided in congress delegate bag.

Sponsorship Package Name: Bronze Sponsor Amount: INR 1,79,000

Facilities: (Excluding 18% GST)

1) 4 complimentary registrations
2) One complimentary exhibition spaces of dimension 3×3 sq.metre (Bare Space)
3) Logo recognition on website, brochure, and all other marketing material and stationery.
.
4) 5 insert provided in congress delegate bag
5) One Speaker Slot(10 min's).
6) Full Page color advertisement in congress program.

Sponsorship Package Name: Silver Sponsor Amount: INR 1,99,000

(Excluding 18% GST)
Facilities:
1) 5 complimentary registrations
2) One complimentary exhibition spaces of dimension 3×3 sq.metre (Bare Space)
3) Logo recognition on website, brochure, and all other marketing material and stationery.
.
4) 7 insert provided in congress delegate bag
5) Two Speaker Slot (10's Minutes Each)
6) Full Page color advertisement in congress program.
Sponsorship Package Name: Gold Sponsor Amount: INR 2,29,000
(Excluding 18% GST)
Facilities:
1) 6 complimentary registrations
2) One complimentary exhibition spaces of dimension 3×3 sq.metre (Bare Space)
3) Logo recognition on website, brochure, and all other marketing material and stationery.
.
4) 10 insert provided in congress delegate bag
5) Three Speaker Slot (10's Minutes Each)
6) Full Page color advertisement in congress program.

Sponsorship Package Name: Session Sponsor Amount: INR 3,99,000

Facilities: (Excluding 18% GST)

1) 12 complimentary registrations
2) One complimentary exhibition spaces of dimension 3×3 sq.metre (Bare Space)
3) Logo recognition on website, brochure, and all other marketing material and stationery.
.
4) 15 insert provided in congress delegate bag
5) A complete session of 1 hour to showcase your product/Panel Discussion
6) 2 Full Page color advertisement in congress program.
7) 1 Speakers slot of 10's minutes during the conference(Main Hall).

Sponsorship Package Name: Diamond Sponsor Amount: INR 6,99,000

(Excluding 18% GST)
Facilities:
1) 50 complimentary registrations
2) One complimentary exhibition spaces of dimension 3×3 sq.metre (Bare Space)
3) .Logo recognition on website, brochure, and all other marketing material and stationery.
4) 15 insert provided in congress delegate bag
5) Dedicated Hall to organise your own Scientific Programme(One Day)
6) 3 Full Page color advertisement in congress program.
7) 2 Speakers slot of 10's minutes during the conference(Main Hall).

Sponsorship Package Name: Bag & Pen Sponsor Amount: INR 89,000
Facilities: (Excluding 18% GST)

1) 1 complimentary registrations
2) Branding on pens and Bag to be used in conference
3) .Logo recognition on website.
Past Sponsors

.
Conference Venue

Venue
JNU Convention Centre

Jawaharlal Nehru University,

New Mehrauli Road, JNU
Ring Rd, Jawaharlal Nehru
University, New Delhi, Delhi
110067

Nearby Locality
Ÿ Airport: 6.7 Km
Ÿ NDLS Railway: 12 KM
Ÿ H Nizamuddin: 10KM
Ÿ BUS: 615, 621
Ÿ Metro Line: Magenta Line
Ÿ Sarojini Nagar: 5 KM

Contct Details

Please contact our Account Manager or our Business Development Manager to discuss sponsor or
exhibitor opportunities at the 8th World Cancer Congress - 2024, New Delhi, India in more detail.

We would be happy to tailor make packages to suit your partnership goals and objectives.

Details of the event are also on our website at https://www.worldcancercongress.in/

Account Managers

+91 7002-412-271
info@worldcancercongress.in
https://www.worldcancercongress.in/
+91 7002-412-271
 CANCER 2024

FOR MORE INFORMATION

REGARDS
MANOJ G | SCIENTIFIC COMMITTEE
CANCER 2024 | Ph: +91 7002-412-271
E: info@worldcancercongress.in
W: https://www.worldcancercongress.in/

HOPE TO SEE YOU @ INDIA

For More Details
W: https://www.worldcancercongress.in/ Ph: +91 7002-412-271